“…To further highlight the heterogeneity of PharmAdvances, this issue features a paper by the group of Dr. Olivero, who is interested in studying pain, its causes, and its modulation by appropriate drugs (6). Unfortunately, we all know how pain (acute and/or chronic) affects quality of life, and pharmacologists are hard at work to fi nd new solutions.…”